News Headline Summary

Bristol Myers (BMY) says study data didn't warrant a phase III study

Reaction details (18:40)

- Co. shares dropped 0.6% in reaction to this headline, moving from USD 32.58 to USD 32.39; trades USD 32.45 last.

03 Dec 2012 - 18:39 - Equities Data - Source: Newswires

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: